DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Lac-Leamy

2026 年 10 月 26 日 7:30 上午 - 2026 年 10 月 27 日 4:00 下午

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 5, Track B: Advancing Pediatric Clinical Trials: Innovation, Regulation, and Operational Excellence

Session Chair(s)

Katalin  Bertenyi, MSc

Katalin Bertenyi, MSc

Manager, Centre for Blood, Blood Products and Biotherapeutics, Health Canada, Canada

Foo-Lim  Yeh, MS

Foo-Lim Yeh, MS

Allergan Aesthetics and Specialty Head, Regulatory Affairs, AbbVie Corporation, Canada

This session will provide an overview of current perspectives on pediatric clinical trials, with emphasis on the regulatory, operational, and scientific considerations that shape study design and delivery. It will bring together perspectives on pediatric platform trial design, an update on Health Canada’s Pediatric Drug Action Plan and its relevance to ongoing pediatric drug development efforts, and practical challenges and opportunities across the pediatric trial landscape. The overall goal is to share strategies that can make pediatric trials more efficient, feasible, and better aligned with practical study execution.

Childhood Cancer Academic-Industry Collaborative Platform Trials (C3PT) Initiative
Elisa Koppelman, Brigham & Women's Hospital

Bringing More Pediatric Clinical Trials to Canada: Challenges, Capacity and Solutions
Thierry Lacaze-Masmonteil, Maternal Infant Child and Youth Research Network (MICYRN)

Natasha Rastogi, Health Canada

Pediatric Standard of Care Clinical Trials Pilot
Eden Story, Health Canada

Learning Objective : At the conclusion of this session, participants should be able to:
  • Summarize the role of pediatric platform trials and other study approaches in advancing pediatric drug development
  • Identify common barriers to pediatric trial execution and strategies to address them
  • Explain the relevance of Health Canada’s Pediatric Drug Action Plan to ongoing pediatric development efforts

Speaker(s)

Elisa  Koppelman, MPH

Childhood Cancer Academic-Industry Collaborative Platform Trials (C3PT) Initiative

Elisa Koppelman, MPH

Team & Program Director, MRCT Center, United States

Thierry  Lacaze-Masmonteil, MD, FRCPC

Bringing More Pediatric Clinical Trials to Canada: Challenges, Capacity and Solutions

Thierry Lacaze-Masmonteil, MD, FRCPC

Scientific Director, Maternal Infant Child and Youth Research Network (MICYRN), Canada

Natasha  Rastogi, MS

Speaker

Natasha Rastogi, MS

Senior Policy Analyst, Health Canada, Canada

Eden  Story

Pediatric Standard of Care Clinical Trials Pilot

Eden Story

, Health Canada, Canada

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。